In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.
Nature. 2017.
PMID: 28723893
Free PMC article.